You are here

  • Home
  • Archive
  • Volume 100, Issue 7
  • Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

Article info

Article menu
Download PDFPDF
Clinical science
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

Authors

  • Hemal Mehta The Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, Australia National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK PubMed articlesGoogle scholar articles
  • Samantha Fraser-Bell The Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, Australia PubMed articlesGoogle scholar articles
  • Aaron Yeung The Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, Australia PubMed articlesGoogle scholar articles
  • Anna Campain The Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, Australia PubMed articlesGoogle scholar articles
  • Lyndell L Lim Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Godfrey J Quin The Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, Australia Ophthalmology Department, Australian School of Advanced Medicine, Macquarie University, Sydney, Australia PubMed articlesGoogle scholar articles
  • Ian L McAllister Lions Eye Institute, Centre for Ophthalmology and Visual Science, University of Western Australia, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Pearse A Keane National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK PubMed articlesGoogle scholar articles
  • Mark C Gillies The Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Hemal Mehta, National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, 162 City Road, London, EC1 V 2PD, UK; HM{at}cantab.net
View Full Text

Citation

Mehta H, Fraser-Bell S, Yeung A, et al
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial
British Journal of Ophthalmology 2016;100:1000-1004.

Publication history

  • Received September 12, 2015
  • Revised October 7, 2015
  • Accepted October 15, 2015
  • First published November 4, 2015.
Online issue publication 
February 19, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/